feed,title,long_url,short_url
MarketWatch,Moderna shares soar premarket after COVID-19 vaccine candidate achieves 94.5% efficacy in Phase 3 trial,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/OmMsHeenArA/story.aspx,https://on.mktw.net/32Og6Uu
MarketWatch,Moderna's COVID-19 vaccine candidate can remain stable for longer in a standard refrigerator,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/ZHRgBcRIkEI/story.aspx,https://on.mktw.net/36A57zi
